ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT) MARKET ANALYSIS

Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Product Type (Instruments and Reagents and Kits), By Technology (Helicase Dependent Amplification (HAD), Nicking Enzyme Amplification Reaction (NEAR), Nucleic Acid Sequence Based Amplification (NASBA), Transcription Medicated Amplification (TMA), Single Primer Isothermal Amplification (SPIA), and Loop-mediated Isothermal Amplification (LAMP)), By Application (Infectious Disease Diagnostics, Blood Screening, and Others), By End User (Academic and Research Institutes, Diagnostic Laboratories, and Others) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : May 2023
Code : CMI2831
Pages :177
Formats :
Excel and PDF
Industry : Biotechnology

Regional Analysis

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market- Regional Analysis

Among region, North America is estimated to hold a dominant position in the global isothermal nucleic acid amplification technology (INAAT) market over the forecast period. North America holds 43.3% of the market share, due to increasing prevalence of chronic diseases in the region. For instance, in 2020, according to Centers for Disease Control and Prevention (CDC), the total number of Americans with chronic diseases was 157 million, with 81 million Similarly, according to GLOBOCAN 2020, 2,281,658 new cancer cases were diagnosed in the U.S., in 2020, with 612,390 fatalities.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa